Related Experiment Videos
[Complications of mitral valve prolapse]
Abstract:
Mitral valve prolapse, usually a benign condition, is aggravated in 15% of the cases by one or the other of five different complications. Mitral regurgitation may develop progressively or abruptly following rupture of the chordae tendinae and requiring prompt surgical repair. Bacterial endocarditis has been observed in 2.9% of the cases, hence the need for preventive antibiotic therapy prior to dental treatments or surgical operations in patients with holosystolic or end-systolic mitral murmur. Among arrhythmias, only ventricular extrasystoles (which are frequent and most often occur in pairs or salvos or are polymorphous) tachycardia and ventricular fibrillation may be considered as true complications of mitral valve prolapse and should be treated initially with beta-blockers. Sudden death is the major complication encountered in 1.4 to 2.4% of the patients; particularly exposed are women around 40 years of age who previously experienced syncopes or episodes of faintness due to attacks of tachycardia or ventricular fibrillation. Ophthalmic or cerebral ischaemic accidents occur with an incidence of 3.5%; some 20 to 30% of subjects under 45 who suffer from these accidents present with mitral valve prolapse.
Insights
Mitral valve prolapse can lead to serious complications like heart valve issues, infections, arrhythmias, and sudden death in some patients. Prompt medical attention is crucial for managing these risks and improving outcomes.
Area of Science:
- Cardiology
- Valvular Heart Disease
Context:
- Mitral valve prolapse (MVP) is often benign but can progress to severe complications in up to 15% of cases.
- Understanding these complications is vital for patient management and risk stratification.
Purpose:
- To outline the primary complications associated with mitral valve prolapse.
- To highlight the incidence and specific patient groups at higher risk for adverse events.
Summary:
- Complications include progressive or acute mitral regurgitation, bacterial endocarditis (2.9% incidence), and specific arrhythmias (ventricular extrasystoles, tachycardia, fibrillation).
- Sudden death affects 1.4-2.4% of patients, particularly women around 40 with a history of syncope. Ophthalmic/cerebral ischemic events occur in 3.5% of patients, with MVP noted in 20-30% of affected individuals under 45.
Impact:
- Informs clinical practice regarding the need for vigilant monitoring and timely intervention in MVP patients.
- Emphasizes the importance of preventive antibiotic therapy and appropriate treatment for arrhythmias and other complications.
- Highlights specific risk factors for sudden death and ischemic events in MVP patients, guiding targeted preventive strategies.